Xenon Pharmaceuticals (XENE) - Analyst Comments

Xenon Pharmaceuticals (XENE) – Analyst Comments

Jan 3, 2024 04:14 PM Citi Starts Xenon Pharmaceuticals (XENE) at Buy, 'Best-In-Class Epilepsy Asset XEN1101 Offers Additional Upside in MDD'
Dec 8, 2023 04:43 AM Baird Starts Xenon Pharmaceuticals (XENE) at Outperform
Oct 2, 2023 02:26 PM
Oct 2, 2023 06:31 AM
Apr 25, 2023 06:33 AM
Dec 14, 2022 03:25 AM
Nov 28, 2022 06:50 AM
Oct 18, 2022 04:39 PM
Jul 21, 2022 04:43 AM
Jul 13, 2022 04:11 PM
Jun 23, 2022 06:42 AM
Jun 23, 2022 06:06 AM
Apr 12, 2022 06:37 AM
Mar 2, 2022 07:54 AM
Oct 28, 2021 05:58 AM
Oct 18, 2021 07:57 AM
Oct 4, 2021 10:39 AM
Oct 4, 2021 08:56 AM
Aug 30, 2021 11:11 AM
Aug 9, 2021 09:10 AM
Apr 26, 2021 08:24 AM
Apr 1, 2021 08:45 AM
Mar 2, 2021 08:09 AM
Jan 14, 2021 08:08 AM
Jul 21, 2020 09:25 AM
May 31, 2020 05:38 PM
Jan 8, 2020 05:59 AM
Sep 20, 2019 07:12 AM
Jun 15, 2018 12:59 PM
Mar 8, 2018 06:02 AM
May 10, 2017 10:35 AM
Mar 13, 2017 06:40 AM
Dec 22, 2016 01:56 PM
Oct 21, 2016 08:40 AM
Sep 26, 2016 06:24 AM
Apr 14, 2016 08:24 AM
Mar 9, 2016 09:41 AM
Oct 30, 2015 07:23 AM
Jul 2, 2015 09:37 AM
Jul 2, 2015 08:47 AM
Mar 13, 2015 08:38 AM
Dec 1, 2014 08:13 AM